Mountain National Bancshares Inc (MNBT) 0.0050

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mountain National Bancshares Inc (MNBT) 0.0050 $MNBT

VIDEO AVAILABLE: Mountain National Bancshares, Inc Announces Extension And Expansion Of Share Repurchase Plan
EWorldWire - Wed Jul 09, 1:30PM CDT
Mountain National Bancshares Inc. (OTCBB: MNBT) (the Company) today announced that its Board of Directors has authorized an expansion of the Company's current share repurchase program. Under this expansion, an additional $300,000 in repurchases of Company common stock has been approved, over and above the initial $500,000 authorization, and the expiration date of the current repurchase program has been extended to June 27, 2009. The stock repurchases are expected to be accomplished in private or open-market purchases. The timing of repurchases and the number of shares of common stock to be purchased and the price at which those shares will be purchased are dependent upon prevailing market conditions, share price, and other factors.

VIDEO AVAILABLE: Mountain National Bancshares Inc. Announce First Quarter Earnings
EWorldWire - Tue Jun 10, 10:10AM CDT
Mountain National Bancshares, Inc. (OTCBB: MNBT), (the "Company" announced today its first quarter 2008 results of operations. Net income for the quarter was $791,000. Basic and diluted earnings per share were $0.32 and $0.31, respectively, for the first quarter of 2008. The Company's net income was $901,000, or $0.42 and $0.39 for basic and diluted earnings per share, respectively, for the first quarter of 2007.

Mountain National Bancshares Inc. Authorizes Stock Repurchase
EWorldWire - Tue Jul 10, 7:10AM CDT
Mountain National Bancshares, Inc. (OTCBB: MNBT) announced today that its Board of Directors has authorized the repurchase of up to $500,000 of the company's common stock prior to June 27, 2008. The stock repurchases are expected to be accomplished in private or open-market purchases. The timing of repurchases and the number of shares of common stock to be purchased is dependent upon prevailing market conditions, share price, and other factors.

Mountain National Bancshares Announces Five Percent Stock Dividend
EWorldWire - Thu Jan 25, 12:30PM CST
Mountain National Bancshares, Inc. (OTCBB: MNBT) today announced that its board of directors has declared a 5% stock dividend payable on February 28, 2007 to shareholders of record on February 15, 2007. As a result of the stock dividend, each shareholder will receive one new share of stock for every 20 shares of stock they hold as of the record date. Fractional shares will not be issued and the company will pay cash in lieu of such fractional shares based on the closing price of the company's common stock on February 15, 2007.

Mountain National Bancshares, Inc. Announces Five Percent Stock Dividend
EWorldWire - Sat May 20, 2:40PM CDT
Mountain National Bancshares, Inc. (OTCBB: MNBT) today announced that its board of directors has declared a five percent stock dividend payable on June 23, 2006 to shareholders of record on June 1, 2006. As a result of the stock dividend, each shareholder will receive one new share of stock for every 20 shares of stock they hold as of the record date. Fractional shares will not be issued and the company will pay cash in lieu of such fractional shares based on the closing price of the company's common stock on June 1, 2006.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 308

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 412

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 130

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 288

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 131

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 127

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Kinetic Seas Incorporated Secures First Customer Success

Updated Category News Views 56

Kinetic Seas Incorporated Secures First Customer and Financial Growth Kinetic Seas Incorporated (OTC: ECGR) is excited to announce the signing of its first customer, along with impressive revenue results for the second quarter. This milestone marks a significant step forward as the company pursues its goals in the artificial intelligence sector. Second Quarter Revenue...

Continue Reading
Webinar Guide for Veterans to Maximize Benefits Offered by CCK Law

Updated Category News Views 134

Helping Veterans Discover VA Benefits with a Free Webinar Chisholm Chisholm & Kilpatrick LTD (CCK Law), a preeminent veterans disability law firm, is excited to introduce a free, on-demand webinar aimed at assisting veterans in uncovering valuable VA benefits that many may be unaware of. Insights from the Experts The webinar, dubbed "Biggest Benefits Veterans Overlook,"...

Continue Reading
Tech Market Shifts: Navigating Opportunities and Challenges Ahead

Updated Category News Views 161

Understanding Recent Market Dynamics In recent weeks, global markets have been experiencing heightened volatility, particularly in the technology sector. With various significant events unfolding—including new political leadership in Japan and shifts in economic data—investors are carefully analyzing these developments to navigate potential risks and opportunities....

Continue Reading
Michael Beland Joins Advance Auto Parts as Chief Accounting Officer

Updated Category News Views 720

Welcome Michael Beland to Advance Auto Parts Advance Auto Parts, Inc. (NYSE: AAP), known for its significant role in the automotive aftermarket, recently made an important announcement regarding its executive leadership. The company has appointed Michael Beland as the new senior vice president, controller, and chief accounting officer, marking a pivotal addition to their...

Continue Reading
Recall Movement Against Governor Newsom Gains Momentum

Updated Category News Views 276

Recall Movement Gains Traction in California In an unprecedented move, SavingCalifornia.vote has taken a significant step to initiate a recall against Governor Gavin Newsom. This initiative marks a pivotal moment in California's political landscape. The organization is gathering support and will soon submit the official notice of intent to recall, alongside the necessary...

Continue Reading